{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T17:49:51Z","timestamp":1793555391388,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017634","name":"Henan University of Chinese Medicine","doi-asserted-by":"publisher","award":["00104311-2023-90"],"award-info":[{"award-number":["00104311-2023-90"]}],"id":[{"id":"10.13039\/100017634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.cbi.2024.111119","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T19:01:33Z","timestamp":1719342093000},"page":"111119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cryptotanshinone alleviates liver fibrosis via inhibiting STAT3\/CPT1A-dependent fatty acid oxidation in hepatic stellate cells"],"prefix":"10.1016","volume":"399","author":[{"given":"Zibo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111119_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111119_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcp.30582","article-title":"Hepatic stellate cells in the injured liver: perspectives beyond hepatic fibrosis","volume":"237","author":"Ezhilarasan","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cbi.2024.111119_bib3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","article-title":"Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.cbi.2024.111119_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111119_bib5","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2024.111119_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2024.111119_bib7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.cbi.2024.111119_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The menage a trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Filali-Mouncef","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2024.111119_bib9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/15548627.2017.1356550","article-title":"Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"issue":"Suppl 2","key":"10.1016\/j.cbi.2024.111119_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1746.2011.07007.x","article-title":"Retinoic acids and hepatic stellate cells in liver disease","volume":"27","author":"Lee","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111119_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhep.2022.02.003","article-title":"Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis","volume":"77","author":"Fondevila","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111119_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.intimp.2017.06.001","article-title":"Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2\/STAT3 signaling in hepatic stellate cells","volume":"49","author":"Lu","year":"2017","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2024.111119_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10238-016-0438-x","article-title":"Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings","volume":"17","author":"Panebianco","year":"2017","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cbi.2024.111119_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13105-011-0101-7","article-title":"Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes","volume":"67","author":"Sauvant","year":"2011","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2024.111119_bib15","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","article-title":"The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis","volume":"67","author":"Xiang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2024.111119_bib16","first-page":"59","article-title":"Danshen: a phytochemical and pharmacological overview","volume":"17","author":"Xd","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.cbi.2024.111119_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/aps.2017.193","article-title":"Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2024.111119_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s11655-021-3293-x","article-title":"Active components formulation developed from Fuzheng Huayu recipe for anti-liver fibrosis","volume":"28","author":"Sun","year":"2022","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.cbi.2024.111119_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3892\/etm.2022.11413","article-title":"Tanshinone IIA regulates the TGF-beta1\/Smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis","volume":"24","author":"Xu","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cbi.2024.111119_bib20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/bph.13766","article-title":"The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy","volume":"174","author":"Ge","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111119_bib21","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.3748\/wjg.v29.i17.2616","article-title":"Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress","volume":"29","author":"Hou","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2024.111119_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/bdd.2213","article-title":"Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats","volume":"41","author":"Wang","year":"2020","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.cbi.2024.111119_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fphar.2020.00193","article-title":"The anticancer properties of tanshinones and the pharmacological effects of their active ingredients","volume":"11","author":"Fu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111119_bib24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ar.25138","article-title":"Lipid droplets, the Holy Grail of hepatic stellate cells: in health and hepatic fibrosis","volume":"306","author":"Mak","year":"2023","journal-title":"Anat. Rec."},{"key":"10.1016\/j.cbi.2024.111119_bib25","article-title":"Mild hypothermia attenuates hepatic ischemia-reperfusion injury through regulating the JAK2\/STAT3-CPT1a-dependent fatty acid beta-oxidation","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cbi.2024.111119_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-Regulated fatty acid beta-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.cbi.2024.111119_bib27","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.cbi.2024.111119_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jhep.2014.03.009","article-title":"Traditional Chinese Medicine (TCM) for fibrotic liver disease: hope and hype","volume":"61","author":"Zhang","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111119_bib29","article-title":"Salvia miltiorrhiza in thorax and abdomainal organ fibrosis: a review of its pharmacology","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111119_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111332","article-title":"A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.111119_bib31","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/ptr.6699","article-title":"Cryptotanshinone reverses the epithelial-mesenchymal transformation process and attenuates bleomycin-induced pulmonary fibrosis","volume":"34","author":"Zhang","year":"2020","journal-title":"Phytother Res."},{"key":"10.1016\/j.cbi.2024.111119_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010265","article-title":"Cryptotanshinone from the Salvia miltiorrhiza Bunge attenuates ethanol-induced liver injury by activation of AMPK\/SIRT1 and Nrf2 signaling pathways","volume":"21","author":"Nagappan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111119_bib33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bcpt.13091","article-title":"Cryptotanshinone attenuates oxidative stress and inflammation through the regulation of Nrf-2 and NF-kappaB in mice with unilateral ureteral obstruction","volume":"123","author":"Wang","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2024.111119_bib34","first-page":"145","article-title":"Cryptotanshinone attenuates isoprenaline-induced cardiac fibrosis in mice associated with upregulation and activation of matrix metalloproteinase-2","volume":"6","author":"Ma","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2024.111119_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbalip.2019.02.004","article-title":"Hepatic stellate cell activation: a source for bioactive lipids","volume":"1864","author":"Shmarakov","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.cbi.2024.111119_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4161\/auto.19947","article-title":"Autophagy fuels tissue fibrogenesis","volume":"8","author":"Hernandez-Gea","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2024.111119_bib37","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","article-title":"Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation","volume":"73","author":"Bates","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111119_bib38","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2024.111119_bib39","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.7150\/thno.21451","article-title":"Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy","volume":"8","author":"Tan","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.cbi.2024.111119_bib40","first-page":"2477","article-title":"The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression","volume":"11","author":"Wang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.cbi.2024.111119_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.06.010","article-title":"STAT3: a key regulator in liver fibrosis","volume":"21","author":"Zhao","year":"2021","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.cbi.2024.111119_bib42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cbi.2024.111119_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114024","article-title":"Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3\/CPT1 pathway","volume":"157","author":"Zheng","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.111119_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jss.2020.12.045","article-title":"HJC0416 attenuates fibrogenesis in activated hepatic stellate cells via STAT3 and NF-kappaB pathways","volume":"261","author":"Sommerhalder","year":"2021","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cbi.2024.111119_bib45","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/cbin.11992","article-title":"Imatinib suppresses activation of hepatic stellate cells by targeting STAT3\/IL-6 pathway through miR-124","volume":"47","author":"Alavifard","year":"2023","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.cbi.2024.111119_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11010-015-2424-0","article-title":"Cryptotanshinone, a Stat3 inhibitor, suppresses colorectal cancer proliferation and growth in vitro","volume":"406","author":"Li","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2024.111119_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.174","article-title":"Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation","volume":"8","author":"Lu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2024.111119_bib48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J. Anim. Physiol. Anim. Nutr."},{"key":"10.1016\/j.cbi.2024.111119_bib49","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1096\/fj.202000678R","article-title":"Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD","volume":"34","author":"Weber","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2024.111119_bib50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2011.10.008","article-title":"Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis","volume":"56","author":"Monsenego","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111119_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114730","article-title":"Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal","volume":"192","author":"Xia","year":"2021","journal-title":"Biochem. Pharmacol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724002655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724002655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T01:16:59Z","timestamp":1727831819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724002655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":51,"alternative-id":["S0009279724002655"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111119","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptotanshinone alleviates liver fibrosis via inhibiting STAT3\/CPT1A-dependent fatty acid oxidation in hepatic stellate cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111119"}}